American Research & Management Company’s United Therapeutics UTHR Stock Holding History

American Research & Management Company’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$28K	Hold	135	–	–	0.01%	232
2022 Q2	$32K	Hold	135	–	–	0.01%	223
2022 Q1	$24K	Hold	135	–	–	0.01%	256
2021 Q4	$29K	Hold	135	–	–	0.01%	235
2021 Q3	$25K	Buy	135 +35	+35%	+$6.89K	0.01%	244
2021 Q2	$18K	Hold	100	–	–	﹤0.01%	281
2021 Q1	$17K	Hold	100	–	–	﹤0.01%	267
2020 Q4	$15K	Hold	100	–	–	﹤0.01%	276
2020 Q3	$10K	Hold	100	–	–	﹤0.01%	263
2020 Q2	$12K	Hold	100	–	–	﹤0.01%	263
2020 Q1	$9K	Hold	100	–	–	﹤0.01%	266
2019 Q4	$9K	Hold	100	–	–	﹤0.01%	275
2019 Q3	$8K	Hold	100	–	–	﹤0.01%	282
2019 Q2	$8K	Hold	100	–	–	﹤0.01%	289
2019 Q1	$12K	Hold	100	–	–	﹤0.01%	313
2018 Q4	$11K	Hold	100	–	–	﹤0.01%	270
2018 Q3	$13K	Hold	100	–	–	﹤0.01%	280
2018 Q2	$11K	Buy	100 +50	+100%	+$5.5K	﹤0.01%	266
2018 Q1	$6K	Hold	50	–	–	﹤0.01%	322
2017 Q4	$7K	Hold	50	–	–	﹤0.01%	316
2017 Q3	$6K	Hold	50	–	–	﹤0.01%	294
2017 Q2	$6K	Hold	50	–	–	﹤0.01%	290
2017 Q1	$7K	Hold	50	–	–	﹤0.01%	274
2016 Q4	$7K	Hold	50	–	–	﹤0.01%	291
2016 Q3	$6K	Hold	50	–	–	﹤0.01%	306
2016 Q2	$5K	Hold	50	–	–	﹤0.01%	298
2016 Q1	$6K	Hold	50	–	–	﹤0.01%	303
2015 Q4	$8K	Hold	50	–	–	﹤0.01%	283
2015 Q3	$7K	Hold	50	–	–	﹤0.01%	301
2015 Q2	$9K	Hold	50	–	–	﹤0.01%	289
2015 Q1	$9K	Hold	50	–	–	﹤0.01%	289
2014 Q4	$6K	Buy	+50	New	+$6.44K	﹤0.01%	309

Other funds holding UTHR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 247.39% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

American Research & Management Company's UTHR Position: Q3 2022 in Review

American Research & Management Company held its United Therapeutics (UTHR) position steady in Q3 2022 at 135 shares worth $28K. The position accounts for 0.01% of the portfolio, ranked #232.

American Research & Management Company first reported a position in UTHR in Q4 2014 and has held it in 32 quarters since. The position peaked at $32K in Q2 2022. 461 funds tracked by Wall St. Rank hold UTHR as of Q3 2022.

American Research & Management Company held 135 shares of United Therapeutics worth $28K as of Q3 2022.
American Research & Management Company left its United Therapeutics share count unchanged in Q3 2022.
United Therapeutics made up 0.01% of American Research & Management Company's portfolio in Q3 2022, its #232 holding.
American Research & Management Company first reported a position in United Therapeutics in Q4 2014 and has held it in 32 quarters since.
American Research & Management Company's United Therapeutics position peaked at $32K in Q2 2022.
461 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2022.

Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.